Literature DB >> 2777382

Virulence, persistence, and immunogenicity of Yersinia enterocolitica O:8 aroA mutants.

F Bowe1, P O'Gaora, D Maskell, M Cafferkey, G Dougan.   

Abstract

The virulent Yersinia enterocolitica strain 8081 killed BALB/c mice within 5 days of oral infection with a 50% lethal dose of log10 7.1, whereas an aroA mutant of 8081, YAM.1, and the plasmidless variant 8081c failed to kill mice. Unlike 8081, YAM.1 and 8081c did not persist or grow in the Peyer's patches, mesenteric lymph nodes, livers, or spleens of mice. Mice immunized orally with single doses of live YAM.1 were poorly protected against a lethal 8081 challenge, whereas mice immunized with three doses of YAM.1 were moderately well protected.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777382      PMCID: PMC260796          DOI: 10.1128/iai.57.10.3234-3236.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Vaccines and cell-mediated immunity.

Authors:  F M Collins
Journal:  Bacteriol Rev       Date:  1974-12

2.  Pathologic features of enteric infection with Yersinia enterocolitica.

Authors:  W D Bradford; P S Noce; L T Gutman
Journal:  Arch Pathol       Date:  1974-07

3.  An inter-familial outbreak of Yersinia enterocolitica enteritis.

Authors:  L T Gutman; E A Ottesen; T J Quan; P S Noce; S L Katz
Journal:  N Engl J Med       Date:  1973-06-28       Impact factor: 91.245

Review 4.  [Human infection with "Yersinia enterocolitica"].

Authors:  H H Mollaret
Journal:  Pathol Biol       Date:  1966-10

5.  Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines.

Authors:  S K Hoiseth; B A Stocker
Journal:  Nature       Date:  1981-05-21       Impact factor: 49.962

6.  Characterization of plasmids and plasmid-associated determinants of Yersinia enterocolitica pathogenesis.

Authors:  D A Portnoy; S L Moseley; S Falkow
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

7.  Pathogenecity of Yersinia enterocolitica for mice.

Authors:  P B Carter
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

8.  Epidemic Yersinia enterocolitica infection due to contaminated chocolate milk.

Authors:  R E Black; R J Jackson; T Tsai; M Medvesky; M Shayegani; J C Feeley; K I MacLeod; A M Wakelee
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

9.  Virulence of Yersinia enterocolitica determined by lethality in Mongolian gerbils and by the Serény test.

Authors:  D A Schiemann; J A Devenish
Journal:  Infect Immun       Date:  1980-08       Impact factor: 3.441

10.  Salmonella typhimurium aroA mutants as carriers of the Escherichia coli heat-labile enterotoxin B subunit to the murine secretory and systemic immune systems.

Authors:  D J Maskell; K J Sweeney; D O'Callaghan; C E Hormaeche; F Y Liew; G Dougan
Journal:  Microb Pathog       Date:  1987-03       Impact factor: 3.738

View more
  22 in total

1.  Oral immunization of mice with a live recombinant Yersinia enterocolitica O:9 strain that produces the cholera toxin B subunit.

Authors:  M P Sory; P Hermand; J P Vaerman; G R Cornelis
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

2.  Molecular characterization of the Aeromonas hydrophila aroA gene and potential use of an auxotrophic aroA mutant as a live attenuated vaccine.

Authors:  C Hernanz Moral; E Flaño del Castillo; P López Fierro; A Villena Cortés; J Anguita Castillo; A Cascón Soriano; M Sánchez Salazar; B Razquín Peralta; G Naharro Carrasco
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

3.  Rational live oral carrier vaccine design by mutating virulence-associated genes of Yersinia enterocolitica.

Authors:  E I Igwe; H Rüssmann; A Roggenkamp; A Noll; I B Autenrieth; J Heesemann
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

4.  Attenuation and vaccine potential of aroQ mutants of Corynebacterium pseudotuberculosis.

Authors:  C P Simmons; A L Hodgson; R A Strugnell
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

5.  Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine.

Authors:  M Jackson; S W Phalen; M Lagranderie; D Ensergueix; P Chavarot; G Marchal; D N McMurray; B Gicquel; C Guilhot
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Molecular gene cloning and nucleotide sequencing and construction of an aroA mutant of Pasteurella haemolytica serotype A1.

Authors:  F M Tatum; R E Briggs; S M Halling
Journal:  Appl Environ Microbiol       Date:  1994-06       Impact factor: 4.792

7.  Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants.

Authors:  Jochen Stritzker; Jozef Janda; Christoph Schoen; Marcus Taupp; Sabine Pilgrim; Ivaylo Gentschev; Peter Schreier; Gernot Geginat; Werner Goebel
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Intracytoplasmic growth and virulence of Listeria monocytogenes auxotrophic mutants.

Authors:  H Marquis; H G Bouwer; D J Hinrichs; D A Portnoy
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

9.  Systematic annotation and analysis of "virmugens"-virulence factors whose mutants can be used as live attenuated vaccines.

Authors:  Rebecca Racz; Monica Chung; Zuoshuang Xiang; Yongqun He
Journal:  Vaccine       Date:  2012-12-06       Impact factor: 3.641

10.  An aromatic-dependent mutant of the fish pathogen Aeromonas salmonicida is attenuated in fish and is effective as a live vaccine against the salmonid disease furunculosis.

Authors:  L M Vaughan; P R Smith; T J Foster
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.